Form 4: Veralto Director Daniel Comas Receives Equity Compensation Grants

Veralto Corp Director Daniel L. Comas reported the acquisition of 818 restricted stock units and 2,265 stock options as part of his compensation.

Summary

• Daniel L. Comas, a Director of Veralto Corp (VLTO), reported changes in his beneficial ownership of company securities.
• On July 15, 2025, Comas acquired 818 shares of Common Stock in the form of restricted stock units (RSUs) at a price of $0.
• These RSUs are structured to vest on the earlier of the first anniversary of the grant date or the date of (and immediately prior to) the next annual meeting of Veralto's shareholders following the grant date.
• The underlying shares for the RSUs are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from Veralto's Board.
• Comas also acquired 2,265 Director Stock Options with an exercise price of $100.95, also at a price of $0.
• These stock options granted to non-employee directors are fully vested as of the grant date (July 15, 2025) and have an expiration date of July 15, 2035.
• Following these transactions, Comas beneficially owns a total of 17,410 shares of Common Stock and 5,860 Director Stock Options.

Sentiment

Score: 5

Explanation: Neutral. This is a routine regulatory filing detailing insider compensation, which is neither inherently positive nor negative for the company's immediate outlook.

Positives

• The equity grants align the director's financial interests with the long-term performance and shareholder value of Veralto Corp.
• The stock options granted are fully vested as of the grant date, providing immediate ownership rights to the director.

Risks

• Potential future dilution for existing shareholders when the restricted stock units convert to shares and when the stock options are exercised, although this is a standard aspect of equity compensation plans.

Future Outlook

The filing details future vesting schedules for restricted stock units, indicating shares will be issued upon the earlier of the director's death or seven months following retirement from Veralto's Board. Stock options are fully vested as of the grant date and expire in 2035.

Industry Context

This Form 4 filing is a routine disclosure of equity compensation for a non-employee director, common across publicly traded companies to align director incentives with shareholder value. It does not provide broader industry trends or competitive analysis.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for minor future dilution upon RSU conversion and option exercise, which is a standard cost associated with attracting and retaining qualified board members.
• Director (Daniel L. Comas): Receives equity-based compensation, aligning personal financial interests with the company's performance and long-term success.

Next Steps

• Restricted stock units will vest on the earlier of the first anniversary of the grant date (July 15, 2025) or the date of the next annual meeting of Veralto's shareholders following the grant date.
• Underlying shares for RSUs will be issued upon the earlier of the director's death or the first date of the seventh month following the director's retirement from Veralto's Board.
• Director stock options are exercisable immediately from the grant date (July 15, 2025) until their expiration on July 15, 2035.

Key Dates

Recommendation

Keywords

Veralto Corp, VLTO, SEC Form 4, Insider Transaction, Beneficial Ownership, Restricted Stock Units, Stock Options, Director Compensation, Equity Grant